theres no business like poh business, page-18

and for new visitors to this forum- there is so much more to the Phosphagenics story than just Transdermal Insulin,

POH has a very full, advanced and lucrative pipeline that has several projects close to commercialisation

R&D Pipeline

The pharmaceutical division is currently engaged in R&D of the following:


Drug Delivery - Transdermal
Morphine Pain Management

Insulin Diabetes


Oxycodone Pain Management

Drug Delivery - Localised
Lidocaine Pain Management

Diclofenac Pain Management

Drug Delivery - Dermal
Retinoic Acid Acne

Drug Enhancement - Oral
Phospha E Metabolic Syndrome



There is also substantial research in Drug enhancement for Atherosclerosis (APA01) and Anti- Cancer GTP-0805

GTP-0805 is an anti-cancer agent with anti-proliferative properties and is thought to exert its activity through modulation of pathways involved in the pathogenesis of cancer.

Then we have Nutraceuticals, This is the use of vitamins and nutritious products to improve human health. The POH nutraceutical business is developing active ingredients for the following market segments:

Dietary Supplements - e.g. vitamin capsules & tablets;
Personal Care - e.g. skin care products; and
Functional Foods and Beverages - e.g. nutritionally enhanced foods.

POH already receives income from global sales of Vital-ET
We are now currently awaiting news on a deal wih Nestle( the worlds largest food co) to use our Phospha E and a new range of Nestle produced functional foods.

So many projects - so many deals to be done